PTPRC and neoplasm: In the LLC subcutaneous tumor model, the percentage of CD45+, CD8+CD45+ lymphocytes in the TPE-IQ-2O PDT group and the ratio of CD8+/CD45+ lymphocytes in the combined group were significantly increased (Figure 8A, P<0.001).